课题基金 / 基金详情

Role of Parkin in Familial and Idiopathic Parkinson's Disease

Role of Parkin in Familial and Idiopathic Parkinson's Disease
Parkin 在家族性和特发性帕金森病中的作用
批准号:
9481344
负责人:
Matthew J Lavoie
金额:
$38.83万
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-08-01 至 2021-05-31

项目摘要

项目成果

Matthew J Lavoie的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Parkinson's disease (PD) is a progressive neurodegenerative disorder characterized by both motor and non- motor disturbances. While the etiology of the disease is unknown, genetic mutations responsible for familial forms of PD likely provide critical molecular insights into the underlying mechanisms of idiopathic disease. Loss-of-function mutations in the ubiquitin E3 ligase parkin are the most common cause of autosomal recessive PD. Parkin is now widely recognized as a pro-survival protein that possesses broad ranging effects on mitochondrial biology, and beyond. A more complete comprehension of these functions will will lead to a firmer understanding of the neurodegenerative process in PD, as well as the identification of new pathways that may be targeted for disease modification. The long-term goal of our work is to uncover the molecular machinery responsible for parkin's protective effects in neurons. We propose that both the cytosolic and mitochondrial-localized pools of parkin play important roles in the maintenance of healthy neurons. This application will explore the role of cytosolic parkin in its neuro-protective function in human neurons. Using engineered isogenic and patient based WT and parkin null pluripotent stem cells differentiated to human neuronal fates, we will uncover the conditions that activate the cytoplasmic pool of parkin. We will identify the upstream proteins that control parkin activation and its protection against cell death in human neurons. Then, we will explore the role of BH3 domains in the recognition of an expanding class of putative substrates of cytoplasmic parkin E3 ligase activity. The pathways found to regulate neuronal parkin function may shed light on innovative targets for therapeutic intervention to up-regulate parkin activity and induce neuro-protection in neurologic disease.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Pathologic LRRK2 signaling in Familial and Idiopathic Parkinson's Disease
  • 批准号:
    9791022
  • 项目类别:
  • 资助金额:
    $45.02万
  • 财政年份:
    2018
  • 负责人:
    Matthew J Lavoie
  • 依托单位:
PATHOLOGIC LRRK2 SIGNALING IN FAMILIAL AND IDIOPATHIC PARKINSON'S DISEASE
  • 批准号:
    10241552
  • 项目类别:
  • 资助金额:
    $35.12万
  • 财政年份:
    2018
  • 负责人:
    Matthew J Lavoie
  • 依托单位:
PATHOLOGIC LRRK2 SIGNALING IN FAMILIAL AND IDIOPATHIC PARKINSON'S DISEASE
  • 批准号:
    10459599
  • 项目类别:
  • 资助金额:
    $35.12万
  • 财政年份:
    2018
  • 负责人:
    Matthew J Lavoie
  • 依托单位:
The Activation of LRRK2 by Alpha-Synuclein
  • 批准号:
    8925936
  • 项目类别:
  • 资助金额:
    $26.0万
  • 财政年份:
    2014
  • 负责人:
    Matthew J Lavoie
  • 依托单位:
国内基金
海外基金
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
  • 批准号:
    LBY21H010001
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2020
  • 负责人:
    郑绪阳
  • 依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
  • 批准号:
    81703335
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    20.0万元
  • 批准年份:
    2017
  • 负责人:
    卫高菲
  • 依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
  • 批准号:
    81670594
  • 项目类别:
    面上项目
  • 资助金额:
    58.0万元
  • 批准年份:
    2016
  • 负责人:
    陈昊
  • 依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
  • 批准号:
    81470791
  • 项目类别:
    面上项目
  • 资助金额:
    73.0万元
  • 批准年份:
    2014
  • 负责人:
    董家鸿
  • 依托单位: